Literature DB >> 17671803

Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens.

A Kedzierska1, P Kochan, A Pietrzyk, J Kedzierska.   

Abstract

Early diagnosis of fungal infections and the implementation of appropriate treatment represent major issues for clinicians, nowadays. Histopathological demonstration of microorganisms in tissue specimens or growth of fungal agents in culture media is still considered the "gold standard", but obtaining such specimens may be difficult. Several groups have investigated serological assays for cell wall elements unique to fungal organisms in serum or other body fluids to improve diagnostics in patients with haematological malignancies or undergoing haematopoietic stem-cell transplantation. In this review we have concentrated on the currently available assays allowing for detection of highly immunogenic components of fungal cell wall: galactomannan, mannan, and also (1-->3)-beta-D-glucan. Rapid serological tests appear to be useful for screening high-risk haematological patients, since they allow for the early diagnosis of invasive fungal infections, including infections with the most common pathogens such as Aspergillus and Candida. Based on current literature, factors increasing the probability of obtaining false-positive or false-negative results detected by each test were also analysed and tabulated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671803     DOI: 10.1007/s10096-007-0373-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  75 in total

1.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

Authors:  J Maertens; J Verhaegen; K Lagrou; J Van Eldere; M Boogaerts
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Transient aspergillus antigenaemia: think of milk.

Authors:  Jean-Pierre Gangneux; Dominique Lavarde; Stéphane Bretagne; Claude Guiguen; Virginie Gandemer
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

3.  Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.

Authors:  Johan A Maertens; Rocus Klont; Christine Masson; Koen Theunissen; Wouter Meersseman; Katrien Lagrou; Christine Heinen; Brigitte Crépin; Johan Van Eldere; Marc Tabouret; J Peter Donnelly; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2007-04-04       Impact factor: 9.079

Review 4.  Trends in the epidemiology of invasive fungal infections.

Authors:  David W Warnock
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2007

Review 5.  International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

Authors:  J E Edwards; G P Bodey; R A Bowden; T Büchner; B E de Pauw; S G Filler; M A Ghannoum; M Glauser; R Herbrecht; C A Kauffman; S Kohno; P Martino; F Meunier; T Mori; M A Pfaller; J H Rex; T R Rogers; R H Rubin; J Solomkin; C Viscoli; T J Walsh; M White
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

6.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Authors:  Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Journal:  Clin Infect Dis       Date:  2005-07-21       Impact factor: 9.079

7.  Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.

Authors:  Makoto Usami; Atsushi Ohata; Takeshi Horiuchi; Koichi Nagasawa; Toshio Wakabayashi; Shigenori Tanaka
Journal:  Transfusion       Date:  2002-09       Impact factor: 3.157

8.  (1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia.

Authors:  A Yasuoka; N Tachikawa; K Shimada; S Kimura; S Oka
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

9.  Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis.

Authors:  Frans M Verduyn Lunel; Andreas Voss; Ed J Kuijper; L B S Gelinck; Peter M Hoogerbrugge; K L Liem; Bart Jan Kullberg; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

10.  Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis.

Authors:  N Kondori; L Edebo; I Mattsby-Baltzer
Journal:  Clin Diagn Lab Immunol       Date:  2004-03
View more
  26 in total

Review 1.  Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.

Authors:  Akira Onishi; Daisuke Sugiyama; Yoshinori Kogata; Jun Saegusa; Takeshi Sugimoto; Seiji Kawano; Akio Morinobu; Kunihiro Nishimura; Shunichi Kumagai
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.

Authors:  P Pini; C Bettua; C F Orsi; C Venturelli; F Forghieri; S Bigliardi; L Faglioni; F Luppi; L Serio; M Codeluppi; M Luppi; C Mussini; M Girardis; Elisabetta Blasi
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

4.  Sequencing and analysis of fungal rRNA operons for development of broad-range fungal PCR assays.

Authors:  Prasanna D Khot; Daisy L Ko; David N Fredricks
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

Review 5.  State of the art diagnostic of mold diseases: a practical guide for clinicians.

Authors:  F Beirão; R Araujo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-18       Impact factor: 3.267

6.  The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.

Authors:  Fang Zheng; Yelian Gu; Hui Zha; Jun Deng; Zhiquan Zhang
Journal:  Mycopathologia       Date:  2016-12-07       Impact factor: 2.574

7.  Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay.

Authors:  P Pini; C Bettua; C F Orsi; C Venturelli; L Faglioni; F Forghieri; S Bigliardi; F Luppi; M Girardis; E Blasi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-01       Impact factor: 3.267

Review 8.  Persistent spontaneous fungal peritonitis secondary to Candida albicans in a patient with alcoholic cirrhosis and review of the literature.

Authors:  Aneela Majeed; Waqas Ullah; Umar Zahid; Mayar Al Mohajer
Journal:  BMJ Case Rep       Date:  2016-11-08

9.  The putative polysaccharide synthase AfCps1 regulates Aspergillus fumigatus morphogenesis and conidia immune response in mouse bone marrow-derived macrophages.

Authors:  Sha Wang; Anjie Yuan; Liping Zeng; Sikai Hou; Meng Wang; Lei Li; Zhendong Cai; Guowei Zhong
Journal:  J Microbiol       Date:  2020-11-17       Impact factor: 3.422

10.  Candidemia on presentation to the hospital: development and validation of a risk score.

Authors:  Andrew F Shorr; Ying P Tabak; Richard S Johannes; Xiaowu Sun; James Spalding; Marin H Kollef
Journal:  Crit Care       Date:  2009-09-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.